October 26

Evidence of Drug Harm that the FDA Sought to Suppress

Evidence of Antidepressant Harm that the FDA Sought to Suppress from FDA’s Public Advisory Committee Meeting on February 2

Evidence was presented on February 2 at AHRP’s press briefing by the following scientists:

AHRP’s written testimony: Where is the Scientific Evidence to Justify Exposing Children to the Risks of Antidepressant Drugs?

FDA Background Memorandum Jan 5, 2004, for Advisory Committee Meeting Re: Suicidality Associated with Antidepressant Drug Treatment.

AHRP correspondence with FDA demonstrating that the FDA would not permit this evidence to be presented at the public hearing:

Feb. 19. Dr. David Healy letter to FDA: updated suicidal evidence not addressed by FDA

Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.

You may also like

September 29, 2022

“Here we will have to really think medical-legal. Why medical-legal? Because [despite] quite a few adverse events

Read More
Israeli Government Officials Concealed Evidence Documenting Irreparable Harm Following Covid-19 Jabs

September 20, 2022

Stop the World Health Organization Treaty that would dictate global public health policy — in other words,

Read More
Vera Sharav Statement Against Efforts by the World Health Organization to Dictate Global Health Policy